SCHEMBL9833656

SCHEMBL9833656

CN(C)CCCN1c2ccccc2Sc2nccnc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 9/20 0.66
CYP1A2 P05177 8/20 0.66
HTR1A P08908 5/20 0.66
TP53 P04637 5/20 0.66
CYP2C19 P33261 4/20 0.66
KDM1A O60341 4/20 0.66
DRD2 P14416 4/20 0.66
CHRM2 P08172 4/20 0.66
ADRA2A P08913 4/20 0.66
CHRM1 P11229 4/20 0.66
DRD1 P21728 4/20 0.66
SLC6A2 P23975 4/20 0.66
SLC6A4 P31645 4/20 0.66
ADRA1A P35348 4/20 0.66
OPRM1 P35372 4/20 0.66
DRD3 P35462 4/20 0.66
KCNH2 Q12809 4/20 0.66
THPO P40225 4/20 0.66
MTOR P42345 4/20 0.66
TSHR P16473 4/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Prothipendyl SCHEMBL29393787 0.86 CYP2D6 (0.72) CYP2D6CYP1A2HTR1ATP53CYP2C19
Prothipendyl SCHEMBL145059 0.86 CYP2D6 (0.72) CYP2D6CYP1A2HTR1ATP53CYP2C19
Prothipendyl SCHEMBL1649843 0.85 CYP2D6 (0.70) CYP2D6CYP1A2HTR1ATP53CYP2C19
Prothipendyl SCHEMBL5705613 0.85 LMNA (0.72) CYP2D6CYP1A2HTR1ATP53CYP2C19
SCHEMBL26238573 0.81 CYP2D6 (0.64) CYP2D6CYP1A2HTR1ATP53CYP2C19
Promazine SCHEMBL123419 0.81 CYP2D6 (0.94) CYP2D6CYP1A2HTR1ATP53CYP2C19
Promazine SCHEMBL9052694 0.80 CYP2D6 (1.00) CYP2D6CYP1A2HTR1ATP53CYP2C19
Promazine SCHEMBL29392545 0.80 CYP2D6 (1.00) CYP2D6CYP1A2HTR1ATP53CYP2C19
Promazine SCHEMBL140489 0.80 CYP2D6 (1.00) CYP2D6CYP1A2HTR1ATP53CYP2C19
Promazine SCHEMBL28239574 0.79 CYP2D6 (0.91) CYP2D6CYP1A2HTR1ATP53CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0140709-B1 5-LIPOXYGENASE INHIBITORS MERCK FROSST CANADA INC. (CA) 1991-04-03 EP disclosed